Dr. Schimmer is a staff physician in the department of Hematology/Oncology at Princess Margaret Cancer Centre, a senior scientist at Ontario Cancer Institute and the head of Experimental Hematology at the University of Toronto. Dr. Schimmer is developing novel therapeutics for the treatment of acute leukemia. Dr. Schimmer is the author of over 135 papers, and is the inventor on over 20 patents and patent applications. He has advanced three drugs with novel mechanisms of action from his lab into clinical trials for patients with acute leukemia. He has received over 30 awards and honours for academic achievement including an award from the Ontario Ministry of Research and Innovation for the best young scientists. In 2007, Dr. Schimmer was named one of Canada's Top 40 Under 40. Dr. Schimmer received the 2012 Till & McCulloch Award, presented each year by the Stem Cell Network in recognition of the year's most influential peer-reviewed article by a researcher in Canada. He also received the 2013 Bernard and Francine Dorval prize, which is awarded by the Canadian Cancer Society to a promising investigator who began their independent research within the previous 10 years and who has made outstanding contributions to basic biomedical research.